⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
Galectin-3 as Systemic Inflammation Marker
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-14 — MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.: Preclinical Gaucher disease study: circulating galectin-3 was elevated in GD mice and patients and decreased with MA-5 treatment in parallel with suppression of cGAS–STING/NLRP3-driven microglial inflammation — supports galectin-3 as a treatment-responsive systemic inflammation readout in a lysosomal/neuroinflammatory disease, not a general aging outcome. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.
14-sep-2026
novelty 3
per-area 3
strengthens